Insider · CIK 0001745566
Mark Oldakowski
Files at BNGO (Bionano Genomics, Inc.). First filing -, latest -.
Mark Oldakowski files SEC Form 4 as COO at BNGO (Bionano Genomics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Mark Oldakowski has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | BNGO Bionano Genomics, Inc. | FTax withholding Common Stock | -27 | $1.30 | $35 | 868 | Jun 3, 2026 |
| Feb 17, 2026 | BNGO Bionano Genomics, Inc. | FTax withholding Common Stock | -20 | $1.10 | $22 | 895 | Feb 18, 2026 |
| Feb 2, 2026 | BNGO Bionano Genomics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +27,737 | $0.00 | $0 | 27,737 | Feb 4, 2026 |
| Sep 11, 2025 | BNGO Bionano Genomics, Inc. | FTax withholding Common Stock | -59 | $4.06 | $240 | 915 | Sep 12, 2025 |
| Sep 11, 2025 | BNGO Bionano Genomics, Inc. | FTax withholding Common Stock | -59 | $4.06 | $240 | 915 | Sep 12, 2025 |
| Jun 3, 2025 | BNGO Bionano Genomics, Inc. | FTax withholding Common Stock | -27 | $3.69 | $100 | 974 | Jun 3, 2025 |
| Mar 14, 2025 | BNGO Bionano Genomics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +6,966 | $0.00 | $0 | 6,966 | Mar 18, 2025 |
| Feb 15, 2025 | BNGO Bionano Genomics, Inc. | FTax withholding Common Stock | -20 | $5.73 | $115 | 1,001 | Feb 19, 2025 |
Questions about Mark Oldakowski
Answered from the filings on this page, as of the latest one.
Is Mark Oldakowski buying or selling?
Mark Oldakowski has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Mark Oldakowski's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mark Oldakowski has 0.
Where does Mark Oldakowski file Form 4?
Mark Oldakowski has filed Form 4 at BNGO (Bionano Genomics, Inc.) as CHIEF OPERATING OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.